Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.02 HKD
Change Today 0.00 / 0.00%
Volume 0.0
512 On Other Exchanges
Hong Kong
As of 4:01 AM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Yan Shao

Chief Executive Officer, Executive Director and Member of Nomination Committee, China Grand Pharmaceutical and Healthcare Holdings Ltd.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Yan Shao has been the Chief Executive Officer at China Grand Pharmaceutical and Healthcare Holdings Ltd. (formerly, MAXX Bioscience Holdings Ltd.) since October 2008. Mr. Yan joined China Grand Pharmaceutical and Healthcare Holdings in March 2008 where he is responsible for overseeing the entire operations and general management of the Group. He served as General Manager of China Grand Pharmaceutical and Healthcare Holdings Ltd. until October 2008. He has over 20 ...

Read Full Background

Corporate Headquarters*

The Center
Central, -- --

Hong Kong

Phone: --
Fax: --

Board Members Memberships*

Chief Executive Officer, Executive Director and Member of Nomination Committee


Guanghua School of Management Beijing University
Beijing Normal University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,499,000

Stock Options*

All Other Compensation$17,000

Total Compensation*

Total Annual Cash Compensation$1,516,000
Total Short Term Compensation$1,499,000
Other Long Term Compensation$17,000
Total Calculated Compensation$1,516,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
512:HK $2.02 HKD 0.00


Bang Liang Li Chairman and General Manager
Huadong Medicine Co., Ltd
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA GRAND PHARMACEUTICAL A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at